-
1
-
-
33748447532
-
The innovator will prevail in glucose monitoring
-
Green MJ. The innovator will prevail in glucose monitoring. Med Device Technol. 2006;17(4):32-3.
-
(2006)
Med Device Technol.
, vol.17
, Issue.4
, pp. 32-33
-
-
Green, M.J.1
-
2
-
-
34147132679
-
Information and communications technology in chronic disease care: What are the implications for paymentr?
-
Cronquist Christensen M, Remler D. Information and communications technology in chronic disease care: what are the implications for paymentr? Med Care Res Rev. 2007;64(2):123-47.
-
(2007)
Med Care Res Rev.
, vol.64
, Issue.2
, pp. 123-147
-
-
Cronquist Christensen, M.1
Remler, D.2
-
3
-
-
33745023859
-
Cost-utility analysis in a UK setting of self-monitoring of blood glucose in patients with type 2 diabetes
-
Palmer AJ, Dinneen S, Gavin JR 3rd, Gray A, Herman WH, Karter AJ. Cost-utility analysis in a UK setting of self-monitoring of blood glucose in patients with type 2 diabetes. Curr Med Res Opin. 2006;22(5):861-72.
-
(2006)
Curr Med Res Opin.
, vol.22
, Issue.5
, pp. 861-872
-
-
Palmer, A.J.1
Dinneen, S.2
Gavin III, J.R.3
Gray, A.4
Herman, W.H.5
Karter, A.J.6
-
4
-
-
85044710382
-
Screening for type 2 diabetes: Literature review and economic modeling
-
Waugh N, Scotland G, McNamee P, Gillett M, Brenna N, Goyder E, Williams R, John A. Screening for type 2 diabetes: literature review and economic modeling. Health Technol Assess. 2007(17);11:1-125.
-
(2007)
Health Technol Assess.
, vol.11
, Issue.17
, pp. 1-125
-
-
Waugh, N.1
Scotland, G.2
McNamee, P.3
Gillett, M.4
Brenna, N.5
Goyder, E.6
Williams, R.7
John, A.8
-
5
-
-
34547210808
-
Economic impacts attributable to the early clinical benefit of atorvastatin therapy - A US managed care perspective
-
Straka RJ, Mamdani M, Damen J, Kuntze CE, Liu LZ, Botteman MF, Koren MJ. Economic impacts attributable to the early clinical benefit of atorvastatin therapy- A US managed care perspective. Curr Med Res Opin. 2007;23(7):1517-29.
-
(2007)
Curr Med Res Opin.
, vol.23
, Issue.7
, pp. 1517-1529
-
-
Straka, R.J.1
Mamdani, M.2
Damen, J.3
Kuntze, C.E.4
Liu, L.Z.5
Botteman, M.F.6
Koren, M.J.7
-
6
-
-
34247334239
-
Lifestyle intervention to prevent diabetes in men and women with impaired glucose tolerance is cost-effective
-
DPS Study Group
-
Lindgren P, Lindström J, Tuomilehto J, Uusitupa M, Peltonen M, Jönsson B, De Faire U, Hellénius ML; DPS Study Group. Lifestyle intervention to prevent diabetes in men and women with impaired glucose tolerance is cost-effective. Int J Technol Assess Health Care. 2007;23(2):177-83.
-
(2007)
Int J Technol Assess Health Care.
, vol.23
, Issue.2
, pp. 177-183
-
-
Lindgren, P.1
Lindström, J.2
Tuomilehto, J.3
Uusitupa, M.4
Peltonen, M.5
Jönsson, B.6
De Faire, U.7
Hellénius, M.L.8
-
7
-
-
34247588162
-
Predicted quality-adjusted life years as a composite measure of the clinical value of diabetes risk factor control
-
Schmittdiel J, Vijan S, Fireman B, Lafata JE, Oestreicher N, Selby JV. Predicted quality-adjusted life years as a composite measure of the clinical value of diabetes risk factor control. Med Care. 2007;45(4):315-21.
-
(2007)
Med Care.
, vol.45
, Issue.4
, pp. 315-321
-
-
Schmittdiel, J.1
Vijan, S.2
Fireman, B.3
Lafata, J.E.4
Oestreicher, N.5
Selby, J.V.6
-
8
-
-
34250211402
-
Impact of a pay-for-performance incentive on support for smoking cessation and on smoking prevalence among people with diabetes
-
Millett C, Gray J, Saxena S, Netuveli G, Majeed A. Impact of a pay-for-performance incentive on support for smoking cessation and on smoking prevalence among people with diabetes. CMAJ. 2007;176(12):1705-10.
-
(2007)
CMAJ.
, vol.176
, Issue.12
, pp. 1705-1710
-
-
Millett, C.1
Gray, J.2
Saxena, S.3
Netuveli, G.4
Majeed, A.5
|